Kh. Anders et al., GIANT-CELL ARTERITIS IN ASSOCIATION WITH CEREBRAL AMYLOID ANGIOPATHY - IMMUNOHISTOCHEMICAL AND MOLECULAR STUDIES (VOL 28, PG 1237, 1997), Human pathology, 29(2), 1998, pp. 205-206
Giant Cell arteritis (GCA) usually manifests as a transmural vascular
infiltrate of mononuclear and multinucleated giant cells (MNGC). We de
scribe six patients with GCA associated with severe cerebral amyloid a
ngiopathy (CAA), all with cerebral hemorrhage or varying degrees of ce
rebral infarct, and histological evidence of Alzheimer's disease (cort
ical CAA often predominating over senile plaques and neurofibrillary t
angles). One case showed mostly cortical involvement (with old microhe
morrhages), and the others were primarily leptomeningeal (with involve
ment of the underlying cortex and extensive encephalomalacia of adjace
nt brain). Many vessels with CAA exhibited a pronounced adventitial an
d perivascular infiltrate of lymphocytes, histiocytes, and MNGC. Immun
ohistochemical staining showed deposition of beta/A4 peptide primarily
in the thickened media of CAA vessels, and within the cytoplasm of MN
GC-suggesting phagocytosis of insoluble peptide. Cystatin C antibody s
tained vascular amyloid and diffusely highlighted astrocytic and MNGC
cytoplasm. HAM56-positive macrophages were frequently seen around amyl
oid-laden vessels. Anti-smooth muscle actin immunohistochemistry sugge
sts the occurrence of medial destruction by amyloid, with relative pre
servation of intimal cells. Ultrastructural studies performed in one c
ase confirmed the presence of intracytoplasmic amyloid in MNGC. The GC
A seen in these cases of CAA most likely represents a foreign body res
ponse to amyloid proteins, causing secondary destruction of the vessel
walt. DNA from brain tissues of five affected patients was examined t
o assess whether mutations were present in exon 17 of the APP gene or
exon 2 of the cystatin C gene, a finding that might explain the foreig
n body giant cell response to amyloid proteins in these cases. However
, restriction fragment mapping of amplified gene segments showed that
previously described mutations were not present in these cases. Copyri
ght (C) 1998 by W.B. Saunders Company.